Thaiger Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.03 Cr
as on 23-10-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -35.63%
(FY 2023)
- Profit -1112.15%
(FY 2023)
- Ebitda -212.66%
(FY 2023)
- Net Worth -3.30%
(FY 2023)
- Total Assets 36.31%
(FY 2023)
About Thaiger Nutraceuticals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Peter Franik, Reshma Ahmed, and Irfan Dhorajiwala serve as directors at the Company.
- CIN/LLPIN
U15490MH2017PTC293981
- Company No.
293981
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2017
- Date of AGM
17 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Thaiger Nutraceuticals Private Limited offer?
Thaiger Nutraceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Fitness Supplements, Surface Coating & Paint Equipment, Powder Coating Machine & Equipment, Nutritional Supplements.
Who are the key members and board of directors at Thaiger Nutraceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Irfan Dhorajiwala  | Director | 18-Apr-2017 | Current |
Peter Franik  | Director | 05-Sep-2018 | Current |
| Reshma Ahmed | Director | 18-Apr-2017 | Current |
Financial Performance of Thaiger Nutraceuticals.
Thaiger Nutraceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.63% decrease. The company also saw a substantial fall in profitability, with a 1112.15% decrease in profit. The company's net worth dipped by a decrease of 3.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thaiger Nutraceuticals?
In 2023, Thaiger Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nova Laboratories Private LimitedActive 7 years 6 monthsPeter Franik, Reshma Ahmed and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Thaiger Nutraceuticals?
Unlock and access historical data on people associated with Thaiger Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thaiger Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thaiger Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
